Emerald Advisers’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-91,561
| Closed | -$6.42M | – | 254 |
|
|
2024
Q1 | $6.42M | Buy |
+91,561
| New | +$6.42M | 0.26% | 111 |
|
|
2023
Q2 | – | Sell |
-237,617
| Closed | -$8.36M | – | 218 |
|
|
2023
Q1 | $8.36M | Sell |
237,617
-234,693
| -50% | -$8.26M | 0.4% | 93 |
|
|
2022
Q4 | $21.6M | Buy |
472,310
+131,700
| +39% | +$6.03M | 1.05% | 38 |
|
|
2022
Q3 | $16.5M | Buy |
340,610
+196,300
| +136% | +$9.51M | 0.85% | 50 |
|
|
2022
Q2 | $5.67M | Buy |
+144,310
| New | +$5.67M | 0.29% | 105 |
|